A Comprehensive Mini Review of Clinical Biochemical Parameters in the Diagnosis of Acute Lymphoblastic Leukemia in Children
DOI:
https://doi.org/10.46966/msjar.v6i3.306Keywords:
Acute lymphoblastic leukemia, Pediatric oncology, Biochemical markersAbstract
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, accounting for up to 30% of all childhood cancers and approximately 80% of childhood leukemias. Despite advances in therapy, ALL remains a significant cause of pediatric cancer mortality, especially in low- and middle-income countries. This review synthesizes data from over fifty peer-reviewed studies to elucidate the role of clinical biochemical parameters—including liver enzymes, lactate dehydrogenase (LDH), uric acid, renal function tests, and proteomic biomarkers—in the diagnosis, prognosis, and monitoring of pediatric ALL. The review also discusses the impact of various treatment modalities on these parameters and highlights the integration of molecular genetics and minimal residual disease (MRD) detection in risk stratification and personalized therapy.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ruweda Ayed Sayhood, Zeyad Tareq Habeeb, Rahem Mahdy Rahem
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
